Report Detail
Global Platinum based Cancer Drug Market Insights, Forecast to 2025
- RnM2319568 |
- 05 March, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin in 2017 is about 71%, and the proportion is in decreasing trend from 2013 to 2017.
Asia-Pacific is the largest market, with a sales market share nearly 53% in 2017. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
The global Platinum based Cancer Drug market is valued at 1290 million US$ in 2018 and will reach 1740 million US$ by the end of 2025, growing at a CAGR of 3.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Platinum based Cancer Drug market based on company, product type, end user and key regions.
This report studies the global market size of Platinum based Cancer Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Platinum based Cancer Drug in these regions.
This research report categorizes the global Platinum based Cancer Drug market by top players/brands, region, type and end user. This report also studies the global Platinum based Cancer Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Market size by Product
Cisplatin
Oxaliplatin
Carboplatin
Other
Market size by End User
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Platinum based Cancer Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Platinum based Cancer Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Platinum based Cancer Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Platinum based Cancer Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Platinum based Cancer Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Platinum based Cancer Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Platinum based Cancer Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Platinum based Cancer Drug Market Size Growth Rate by Product
- 1.4.2 Cisplatin
- 1.4.3 Oxaliplatin
- 1.4.4 Carboplatin
- 1.4.5 Other
- 1.5 Market by End User
- 1.5.1 Global Platinum based Cancer Drug Market Size Growth Rate by End User
- 1.5.2 Colorectal Cancer
- 1.5.3 Ovarian Cancer
- 1.5.4 Lung Cancer
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Platinum based Cancer Drug Market Size
- 2.1.1 Global Platinum based Cancer Drug Revenue 2014-2025
- 2.1.2 Global Platinum based Cancer Drug Sales 2014-2025
- 2.2 Platinum based Cancer Drug Growth Rate by Regions
- 2.2.1 Global Platinum based Cancer Drug Sales by Regions
- 2.2.2 Global Platinum based Cancer Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Platinum based Cancer Drug Sales by Manufacturers
- 3.1.1 Platinum based Cancer Drug Sales by Manufacturers
- 3.1.2 Platinum based Cancer Drug Sales Market Share by Manufacturers
- 3.1.3 Global Platinum based Cancer Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Platinum based Cancer Drug Revenue by Manufacturers
- 3.2.1 Platinum based Cancer Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Platinum based Cancer Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Platinum based Cancer Drug Price by Manufacturers
- 3.4 Platinum based Cancer Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Platinum based Cancer Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Platinum based Cancer Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Platinum based Cancer Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Platinum based Cancer Drug Sales by Product
- 4.2 Global Platinum based Cancer Drug Revenue by Product
- 4.3 Platinum based Cancer Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Platinum based Cancer Drug Breakdown Data by End User
6 North America
- 6.1 North America Platinum based Cancer Drug by Countries
- 6.1.1 North America Platinum based Cancer Drug Sales by Countries
- 6.1.2 North America Platinum based Cancer Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Platinum based Cancer Drug by Product
- 6.3 North America Platinum based Cancer Drug by End User
7 Europe
- 7.1 Europe Platinum based Cancer Drug by Countries
- 7.1.1 Europe Platinum based Cancer Drug Sales by Countries
- 7.1.2 Europe Platinum based Cancer Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Platinum based Cancer Drug by Product
- 7.3 Europe Platinum based Cancer Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Platinum based Cancer Drug by Countries
- 8.1.1 Asia Pacific Platinum based Cancer Drug Sales by Countries
- 8.1.2 Asia Pacific Platinum based Cancer Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Platinum based Cancer Drug by Product
- 8.3 Asia Pacific Platinum based Cancer Drug by End User
9 Central & South America
- 9.1 Central & South America Platinum based Cancer Drug by Countries
- 9.1.1 Central & South America Platinum based Cancer Drug Sales by Countries
- 9.1.2 Central & South America Platinum based Cancer Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Platinum based Cancer Drug by Product
- 9.3 Central & South America Platinum based Cancer Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Platinum based Cancer Drug by Countries
- 10.1.1 Middle East and Africa Platinum based Cancer Drug Sales by Countries
- 10.1.2 Middle East and Africa Platinum based Cancer Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Platinum based Cancer Drug by Product
- 10.3 Middle East and Africa Platinum based Cancer Drug by End User
11 Company Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sanofi Platinum based Cancer Drug Products Offered
- 11.1.5 Sanofi Recent Development
- 11.2 Hengrui Medicine
- 11.2.1 Hengrui Medicine Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Hengrui Medicine Platinum based Cancer Drug Products Offered
- 11.2.5 Hengrui Medicine Recent Development
- 11.3 ASK Pharma
- 11.3.1 ASK Pharma Company Details
- 11.3.2 Company Business Overview
- 11.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 ASK Pharma Platinum based Cancer Drug Products Offered
- 11.3.5 ASK Pharma Recent Development
- 11.4 Yi Bai Pharmaceutical
- 11.4.1 Yi Bai Pharmaceutical Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Products Offered
- 11.4.5 Yi Bai Pharmaceutical Recent Development
- 11.5 Qilu Pharmaceutical
- 11.5.1 Qilu Pharmaceutical Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Products Offered
- 11.5.5 Qilu Pharmaceutical Recent Development
- 11.6 Teva
- 11.6.1 Teva Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Teva Platinum based Cancer Drug Products Offered
- 11.6.5 Teva Recent Development
- 11.7 Pfizer
- 11.7.1 Pfizer Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Pfizer Platinum based Cancer Drug Products Offered
- 11.7.5 Pfizer Recent Development
- 11.8 Dr Reddy's Laboratories
- 11.8.1 Dr Reddy's Laboratories Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Products Offered
- 11.8.5 Dr Reddy's Laboratories Recent Development
- 11.9 Mylan
- 11.9.1 Mylan Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Mylan Platinum based Cancer Drug Products Offered
- 11.9.5 Mylan Recent Development
- 11.10 Sun Pharma
- 11.10.1 Sun Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Sun Pharma Platinum based Cancer Drug Products Offered
- 11.10.5 Sun Pharma Recent Development
- 11.11 Novartis
- 11.12 Debiopharm
- 11.13 Accord Healthcare
- 11.14 SK Chemicals
12 Future Forecast
- 12.1 Platinum based Cancer Drug Market Forecast by Regions
- 12.1.1 Global Platinum based Cancer Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Platinum based Cancer Drug Revenue Forecast by Regions 2019-2025
- 12.2 Platinum based Cancer Drug Market Forecast by Product
- 12.2.1 Global Platinum based Cancer Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Platinum based Cancer Drug Revenue Forecast by Product 2019-2025
- 12.3 Platinum based Cancer Drug Market Forecast by End User
- 12.4 North America Platinum based Cancer Drug Forecast
- 12.5 Europe Platinum based Cancer Drug Forecast
- 12.6 Asia Pacific Platinum based Cancer Drug Forecast
- 12.7 Central & South America Platinum based Cancer Drug Forecast
- 12.8 Middle East and Africa Platinum based Cancer Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Platinum based Cancer Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Platinum based Cancer Drug . Industry analysis & Market Report on Platinum based Cancer Drug is a syndicated market report, published as Global Platinum based Cancer Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Platinum based Cancer Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
